The Enterprise Value as of December 2025 (TTM) for Pharmaron Beijing Co., Ltd. (300759.SZ) is 48.66B

According to Pharmaron Beijing Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 48.66B. This represents a change of -10.38% compared to the average of 54.29B of the last 4 quarters.

Pharmaron Beijing Co., Ltd. (300759.SZ) Historical Enterprise Value (quarterly & annually)

How has 300759.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Pharmaron Beijing Co., Ltd. over the last ten years is 30.85B. The current 48.66B Enterprise Value has changed 15.67% with respect to the historical average. Over the past ten years (40 quarters), 300759.SZ's Enterprise Value was at its highest in in the January 2023 quarter at 84.25B. The Enterprise Value was at its lowest in in the March 2018 quarter at 3.20B.

Pharmaron Beijing Co., Ltd. (300759.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pharmaron Beijing Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pharmaron Beijing Co., Ltd. (300759.SZ) Average Enterprise Value

How has 300759.SZ Enterprise Value performed in the past?

The current Enterprise Value of Pharmaron Beijing Co., Ltd. (300759.SZ) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Pharmaron Beijing Co., Ltd. (300759.SZ) Enterprise Value vs. Peers

How is 300759.SZ’s Enterprise Value compared to its peers?

Pharmaron Beijing Co., Ltd.’s Enterprise Value is greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (36.85B), greater than Shanghai Allist Pharmaceuticals Co., Ltd. (45.30B), greater than Shanghai RAAS Blood Products Co., Ltd. (43.45B), greater than Shenzhen New Industries Biomedical Engineering Co., Ltd. (45.05B), less than Chongqing Zhifei Biological Products Co., Ltd. (57.87B), greater than RemeGen Co Ltd (45.85B), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (25.23B), greater than Imeik Technology Development Co.,Ltd. (42.80B), greater than Beijing Tiantan Biological Products Co., Ltd. (30.84B), greater than Beijing Tongrentang Co., Ltd (38.21B),

Build a custom stock screener for Pharmaron Beijing Co., Ltd. (300759.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmaron Beijing Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmaron Beijing Co., Ltd. (300759.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmaron Beijing Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.